Pancreas reawakens: CF drug may let kids ditch daily enzyme pills
NCT ID NCT07632768
First seen Jun 10, 2026 · Last updated Jun 16, 2026 · Updated 1 time
Summary
This study looked at whether children with cystic fibrosis whose pancreas function improved after taking CFTR modulators could safely stop taking pancreatic enzyme replacement therapy (PERT). Seventeen children were followed for six months to check their growth, digestion, and nutrition. The goal was to see if stopping enzymes caused any problems or if the pancreas stayed healthy on its own.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.